Brief: MiNK Therapeutics Q2 EPS USD -0.62
13/08/2026 12:31
BRIEF-MiNK Therapeutics Q2 EPS USD -0.62 Aug 13 (Reuters) - MiNK Therapeutics Q2 net income USD -3.1 million.
Recent news on Mink Therapeutics
See all newsMiNK Therapeutics Q2 loss narrows on expense discipline
Brief: MiNK Therapeutics Q2 EPS USD -0.62
Mink Therapeutics Inc expected to post a loss of 60 cents a share - Earnings Preview
Brief: MiNK Therapeutics Says No Major Serious Adverse Events Attributed To Agent-797 In First Patients
U.S. STOCKS ON THE MOVE-Snowflake, Best Buy, Kohl's